Diabetic Macular Edema Drug Approved

March 25, 2015 3:29 PM

8 0

The US Food and Drug Administration (FDA) approved a new use for aflibercept (Eyelea/Regeneron). The FDA ruled today that the drug may be used to treat diabetic retinopathy in patients with diabetic macular edema (DME). The drug is already in use for treating age-related wet macular degeneration.

It is the second drug approved this year to treat DME. In February, the FDA approved ranibizumab (Lucentis/Genentech) for that use.

Read more

To category page